{"id":"NCT00546481","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.","officialTitle":"An Open-label, Randomized, Multi-center, Parallel Group Study to Demonstrate Correction of Anemia Using Intravenous Injections of RO0503821 in Patients With Chronic Kidney Disease Who Are on Dialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2009-12","completion":"2009-12","firstPosted":"2007-10-19","resultsPosted":"2016-07-18","lastUpdate":"2016-09-19"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"methoxy polyethylene glycol-epoetin beta [RO0503821, Mircera]","otherNames":[]},{"type":"DRUG","name":"Epoetin","otherNames":[]}],"arms":[{"label":"Correction Phase: CERA","type":"EXPERIMENTAL"},{"label":"Correction Phase: Epoetin Beta","type":"ACTIVE_COMPARATOR"}],"summary":"This 2 arm study will evaluate the efficacy of intravenous Mircera treatment for the correction of anemia in patients with chronic kidney disease who are on dialysis. Patients will be randomized to receive either Mircera 0.6 micrograms/kg i.v. every 2 weeks, or epoetin 3 times per week i.v. according to approved treatment recommendations. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Hemoglobin Response up to Week 24","timeFrame":"Up to Week 24","effectByArm":[{"arm":"Correction Phase: CERA","deltaMin":79.5,"sd":null},{"arm":"Correction Phase: Epoetin Beta","deltaMin":87.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":7,"countries":["South Korea"]},"refs":{"pmids":["24431909"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":38},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Diarrhoea","Constipation","Procedural hypotension"]}}